Pregabalin PCD Pharma Franchise Company
Cafoli Lifecare is a WHO-GMP certified Pregabalin PCD pharma franchise company offering 28 Pregabalin formulations across Capsule, Tablets. Every batch is manufactured in DCGI-approved, WHO-GMP compliant facilities and supplied to franchise partners on a monopoly basis with full promotional backing.
What is Pregabalin?
Pregabalin is an anticonvulsant and neuropathic pain agent, a structural analogue of GABA. It binds the alpha-2-delta auxiliary subunit of voltage-gated calcium channels in the central nervous system, reducing calcium influx at nerve terminals and thereby the release of excitatory neurotransmitters such as glutamate and substance P. It is used for neuropathic pain, as adjunctive therapy in partial-onset seizures, and in generalised anxiety disorder. See the compound record on PubChem.
Pregabalin Range Available for Franchise
Our Pregabalin portfolio comprises 28 formulations available in the following dosage forms: Capsule, Tablets. Brand names, compositions, packing and net rates are shared on request with partners holding a valid Drug License. Contact us for the current Pregabalin price list and stock position.
Therapeutic Applications of Pregabalin
Pregabalin is indicated in diabetic peripheral neuropathy, post-herpetic neuralgia, fibromyalgia, spinal-cord-injury-associated neuropathic pain, and as adjunctive treatment in partial-onset epilepsy. It is commonly combined with methylcobalamin, nortriptyline or duloxetine in fixed-dose combinations. Prescribers include neurologists, orthopaedic surgeons, diabetologists, pain-management specialists, psychiatrists and consulting physicians.
Compliance note: pregabalin has recognised potential for misuse and dependence and is a prescription-only medicine in India. Franchise partners must hold a valid Drug License and supply it only against a registered medical practitioner's prescription, with proper sales records maintained.
Why Pregabalin is a High-Potential Molecule for Distributors
Pregabalin sits at the intersection of India's two largest chronic disease burdens — diabetes and spinal/musculoskeletal degeneration — which is why diabetic peripheral neuropathy alone gives it an enormous and steadily expanding patient pool. Neuropathic pain is treated over months to years, not days, so the molecule behaves like a chronic-therapy product with sustained monthly refills. Its combinability is the second driver: pairing with methylcobalamin, nortriptyline or duloxetine produces a wide SKU spread, which is exactly why our portfolio runs to 28 formulations. For a distributor, one molecule can support both an orthopaedic panel and a diabetology panel from the same stock.
Why Choose Cafoli Lifecare for Your Pregabalin Franchise
Cafoli Lifecare works with over 1000+ franchise partners across India. Partners receive monopoly rights for their district or territory, WHO-GMP certified and DCGI-approved products, complete promotional inputs (visual aids, MR bags, samples, prescription pads, gifts), transparent net rates, and dependable dispatch. Our documentation and stock support are built for distributors who want to scale without operational friction.
References
- PubChem — Pregabalin compound record (NIH / NCBI)
- MedlinePlus — Pregabalin drug information (US National Library of Medicine)
- PubMed — clinical literature on Pregabalin
Our formulations of Pregabalin find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: